Compass is the most advanced company in classic psychedelics and has generated positive data from two ongoing large, well controlled Phase 3 clinical trials, designed to uphold the highest regulatory ...
The Food and Drug Administration (FDA) on Friday granted fast-track review to three companies studying psychedelic therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results